| Project/Area Number |
18K10372
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Review Section |
Basic Section 58060:Clinical nursing-related
|
|---|
| Research Institution | Mukogawa Women's University |
|---|
Principal Investigator |
Nunotani Maya 武庫川女子大学, 看護学部, 教授 (70514735)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
中山 和弘 聖路加国際大学, 大学院看護学研究科, 教授 (50222170)
石橋 千夏 奈良県立医科大学, 医学部, 講師 (30564976)
|
|---|
| Project Period (FY) |
2018-04-01 – 2022-03-31
|
| Project Status |
Completed (Fiscal Year 2021)
|
| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2021: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2020: ¥390,000 (Direct Cost: ¥300,000、Indirect Cost: ¥90,000)
Fiscal Year 2019: ¥390,000 (Direct Cost: ¥300,000、Indirect Cost: ¥90,000)
Fiscal Year 2018: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
|
|---|
| Keywords | クローン病 / ディシジョン・エイド / 生物学的治療 / 意思決定 / Shared decision making |
|---|
| Outline of Final Research Achievements |
The study aim was to develop a decision aid for patients with Crohn’s disease considering biologic treatment. First, we conducted a nationwide online survey of gastroenterologists who had treated patients with Crohn’s disease in Japan. According the results, a decision aid prototype was systematically created based on the Ottawa Decision Support Framework. A questionnaire survey was designed to assess the prototype’s usability, validity, and acceptability. The survey was completed by 18 patients and 6 clinicians. Results of the survey indicate that this DA is useful, acceptable and valued by patients and clinicians and meets a significant gap in the resources available for patients. We created an evidence-based decision aid after modifying a prototype according to the survey results of free responses.
|
| Academic Significance and Societal Importance of the Research Achievements |
本研究成果の学術的意義はオタワ意思決定支援フレームワークやInternational Patient Decision Aid Standards instrumentの基準をもとに系統的プロセスでディシジョン・エイドを開発した点である。
本研究成果の社会的意義は意思決定支援を可視化する点である。エイドを活用することで、医療者の提示したい情報と患者の持つ価値観の見える化が図られ、患者と医療者の共有による意思決定を実現しやすくなると考える。クローン病患者は年々増加しており、新たな生物学的治療薬の開発が進んでいる現状から、開発したディシジョン・エイドは患者中心の意思決定支援に貢献できると考える。
|
